(IN BRIEF) Sanofi’s Dupixent has been granted FDA priority review for the treatment of bullous pemphigoid (BP), a chronic skin disease. If approved, Dupixent would be the first targeted medicine for BP in the U.S., with the FDA’s decision expected … Read the full press release
Posted in Business, Financial, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged bullous pemphigoid, chronic conditions, clinical trial, corticosteroid, disease remission, Dupixent, Dupixent sBLA, FDA approval, FDA priority review, orphan drug designation, regulatory news, Sanofi, skin disease, targeted treatment
(IN BRIEF) Recent studies suggest that current cardiovascular risk assessment methods may be inadequate and call for a more personalized approach. Tools like carotid ultrasound offer promising solutions for more precise evaluations, enabling targeted interventions such as aspirin therapy, which … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged aspirin therapy, Bayer, cardiovascular disease, cardiovascular health, Cardiovascular risk, carotid ultrasound, coronary artery calcium scoring, Dr. Michael Blaha, Dr. Ricardo Salazar, healthcare access, heart disease prevention, ischemic events, medical research, personalized medicine, risk assessment, stroke prevention, subclinical atherosclerosis, subclinical plaque
(IN BRIEF) Telefónica, in collaboration with Vithas, LuxQuanta, and QoolNet, has successfully implemented a Quantum Key Distribution (QKD) system to protect healthcare data transmitted between two hospitals in Madrid. This project marks a significant step toward ensuring the security of … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Science, Security & Safety, Spain, Technology, Telecom
Tagged Cybersecurity, encryption, fiber-optic network, Fortinet, healthcare communications, healthcare data security, INNOVATION, LuxQuanta, Madrid, Mobile World Congress, partnership, patient information, QKD, QoolNet, quantum computing, quantum key distribution, quantum-safe communications, Telefonica, Vithas
(IN BRIEF) On February 13, Jenoptik CFO and patron of the Parents’ Initiative, Prisca Havranek-Kosicek, presented a record donation to the Jena Parents’ Initiative for Children with Cancer during the “Heroes’ Celebration” at the pediatric cancer ward of Jena University … Read the full press release
Posted in Business, Electronics & Machinery, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged cancer treatment, childhood cancer support, children with cancer, Christmas party, donation, EKK, employee contributions, fundraising, Heroes' Celebration, International Children’s Cancer Day, Jena, Jena Parents' Initiative for Children with Cancer, Jena University Hospital, Jena-based association, Jenoptik, medical support, Prisca Havranek-Kosicek, summer festival, therapy dogs
(IN BRIEF) Researchers from The Institute of Cancer Research, London, and Barts Cancer Institute have discovered how the extracellular matrix (ECM) surrounding tumours influences cancer cells to become aggressive and spread throughout the body. Their study, published in Nature Communications, … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged Barts Cancer Institute, breast cancer, cancer metastasis, cancer research, Cancer Therapies, cancer treatment, early cancer detection, ECM, extracellular matrix, ICR, lysyl oxidase, melanoma, metastasis, metastasis prevention, Nature Communications, tumor behavior, tumor biology
(IN BRIEF) A study by the Technical University of Munich (TUM), LMU Hospital Munich, and Helmholtz Munich found that while intermittent fasting benefits adult mice by improving insulin sensitivity, it harms beta cell development in adolescent mice, which could have … Read the full press release
Posted in Business, Education, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged adolescent mice, adolescents, Alexander Bartelt, beta cell function, Cell Reports, cellular development, diabetes treatment, dietary practices, Health Risks, Helmholtz Munich, insulin sensitivity, insulin-producing beta cells, intermittent fasting, LMU Hospital Munich, metabolic health, METABOLISM, single-cell sequencing, Stephan Herzig, Technical University of Munich, teenage health, TUM, type 1 diabetes, type 2 diabetes
(IN BRIEF) A study conducted by the University of Southampton reveals significant challenges faced by paramedics in responding to end-of-life patients in England. Key issues identified include a lack of patient information, barriers to medication administration, and insufficient training, which … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged advance care planning, ambulances, anticipatory medications, BMC Palliative Care, Dr Natasha Campling, Dr Sarah Holmes, end-of-life care, frailty, healthcare challenges, healthcare professionals, heart failure, hospital transfer, Marie Curie, medication administration, medication barriers, National Institute for Health and Care Research, NHS trusts, NIHR Applied Research Collaboration Wessex, palliative care, paramedics, patient care, patient information, Professor Sue Latter, training, University of Southampton
(IN BRIEF) The £2.3 million CHART trial, set to launch in February 2025, will test the impact of Comprehensive Geriatric Assessment (CGA) in helping older adults with heart failure and frailty maintain or improve their daily activities. The trial aims … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged Bradford Teaching Hospitals NHS Foundation Trust, care plan, CGA, CHART trial, Comprehensive Geriatric Assessment, frailty, heart failure, independence, integrated care, Lauren Walker, long-term health conditions, multimorbidity, National Institute for Health and Care Research, NIHR Applied Research Collaborations, NIHR Health Technology Assessment programme, Northern Care Alliance NHS Foundation Trust, Older Adults, partnership, patient-centered care, quality of life, South West Peninsula, University of Exeter, University of Leeds, University of Liverpool, Yorkshire & Humber
(IN BRIEF) After over a decade of leading the MRC-University of Glasgow Centre for Virus Research (CVR), Professor Massimo Palmarini is stepping down as Director to take on the role of Head of Viroscience at Erasmus University Medical Centre in … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged apppointment, COVID-19, cross-species transmission, cryo-EM microscopes, CVR, drug-resistance screening hub, Ebola, Emerging Infectious Diseases, Erasmus University Medical Centre, global virus research, Head of Viroscience, hepatitis, human-animal interface, influenza, leadership, Medical Research Council, MRC, MRC-University of Glasgow Centre for Virus Research, Professor Emma Thomson, Professor Iain McInnes, Professor Massimo Palmarini, public health, University of Glasgow, vaccine trials, viral diseases, viral sequencing, virus pathogenesis, ZIKA
(IN BRIEF) Alexion, AstraZeneca Rare Disease, has partnered with DHL Express to become the first company in Ireland to fully transition its air freight operations to 100% Sustainable Aviation Fuel (SAF). This switch will reduce greenhouse gas emissions by over … Read the full press release
Posted in Aviation & Aerospace, Business, Energy, Gas & Oil, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, Transportation & Logistics, United Kingdom
Tagged 2050 net-zero goal, air freight, Alexion, AstraZeneca Rare Disease, AstraZeneca sustainability strategy, decarbonization, DHL Express, Emissions Reduction, environmental stewardship, Europe, European countries, global supply chain, GoGreen Plus service, greenhouse gas emissions, medicine transportation, net-zero emissions, partnership, SAF, Scope 3 emissions, Scope 3 GHG emissions, sustainability, sustainable aviation fuel
(IN BRIEF) Novartis has announced its acquisition of Anthos Therapeutics, a Boston-based biopharmaceutical company focused on developing abelacimab, an investigational monoclonal antibody currently in Phase 3 trials for preventing stroke and systemic embolism in patients with atrial fibrillation. This acquisition … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged abelacimab, acquisition, Anthos Therapeutics, anticoagulation, atrial fibrillation, biopharmaceutical company, Blackstone Life Sciences, bleeding reduction, Boston, cancer-associated thrombosis, cardiovascular, cardiovascular therapeutic area, clinical-stage, David Soergel, Factor XI inhibition, Fast Track Designation, FDA, medical research, Novartis, partnership, Phase 3 trials, regulatory milestones, Shreeram Aradhye, stroke prevention, systemic embolism, therapeutic focus, thrombosis
(IN BRIEF) The Conference Forum has announced the 9th annual Patients as Partners® Europe event, scheduled for May 20-21, 2025, at the Royal National Hotel in London. This event offers a platform for pharma R&D and patient advocacy to discuss … Read the full press release
Posted in France, Healthcare, Marketing, Pharma & Biotech, Science, Switzerland, United Kingdom
Tagged Alfred Samuels, AstraZeneca, Azafaros, Beyza Klein, Biotech, Biotechnology Conference, Boehringer Ingelheim, Bre Bugbee-Barrett, Catherine Coulouvrat MD, Chiesi Farmaceutici SpA, clinical development, clinical operations, clinical research, clinical research enterprise, clinical trial, clinical trials, Conference Forum, decentralized clinical trials, Gisela Linthorst, GSK, Harry Verbunt, HTA/Regulatory requirements, Johnson & Johnson Innovative Medicine, Lea-Isabelle Proulx PhD, life post-cancer diagnosis, Marisa Minetti, Medicine Development, Patient Advocacy, patient engagement, patient engagement in drug development, patient experience, Patient Recruitment, Patient Retention, Patients as Partners, Patients as Partners Europe, Peter DiBiaso, pharma, Pharmaceutical Conference, Regeneron, research and development, Roche, Royal National Hotel, Sanofi, Temi Olonisakin MD, The Conference Forum, Valerie Bowling
(IN BRIEF) Amadix, a Spanish biotech company focused on non-invasive blood tests for early cancer detection, has secured a €15 million loan from the European Investment Bank (EIB). This funding, backed by InvestEU, will support Amadix in advancing its blood … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Healthcare, Industrial, Investment, Luxembourg, Management, News, Science, Spain, Technology
Tagged AI, Amadix, artificial intelligence, colorectal cancer, DiagnoLung, digitalization, early cancer detection, Early Detection, EIB, EU Beating Cancer Plan, European Investment Bank, European medtech startups, InvestEU, life sciences, liquid biopsy, miRNAs, non-invasive blood tests, PancreaDix, partnership, PreveCol, protein analysis, Rocío Arroyo, sustainability, technological innovation, U.S. market, Valladolid, €15 million loan
(IN BRIEF) The GEMINI study, the largest of its kind, has revealed significant genetic overlaps in 72 long-term health conditions related to aging. Conducted by the University of Exeter Medical School and funded by the Medical Research Council and the … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged aging, B12 deficiency, BAAINBw, disease overlaps, Dr. Joao Delgado, eBioMedicine, GEMINI study, genetic analysis, genetic factors, genetic overlaps, health research, healthcare services, iron deficiency anaemia, long-term health conditions, Medical Research Council, multimorbidity, multimorbidity prevention, National Institute for Health Research, NIHR, patient records, Personalized Treatment, prevention, primary care, Professor Jane Masoli, treatment, University of Exeter Medical School
(IN BRIEF) Unilever has announced its partnership with UEFA as an official sponsor for UEFA Women’s EURO 2025, with several of its leading brands, including Hellmann’s, Knorr, Dove, and Rexona, supporting the tournament. This collaboration builds on Unilever’s successful sponsorship … Read the full press release
Posted in Apparel, Fashion & Beauty, Business, Commodities, Entertainment, Financial, Food & Beverage, Government, Healthcare, Industrial, Investment, Management, Media, News, Sports, United Kingdom
Tagged brand partnership, consumer engagement, Dove, FIFA World Cup™, football tournament, global sports sponsorship, Hellmann’s, Knorr, marketing, partnership, Rexona, sponsorship, sports campaigns, Sports Sponsorship, Switzerland, UEFA, UEFA EURO 2024™, UEFA Women’s EURO 2025, Unilever, women’s football, Women’s World Cup
(IN BRIEF) Basilea Pharmaceutica Ltd announced that its antifungal drug, Cresemba® (isavuconazole), surpassed sales targets in Japan, triggering a CHF 1.2 million sales milestone payment from its partner Asahi Kasei Pharma. This achievement, reached in just the second year of … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Antifungal Drug, Asahi Kasei Pharma, Basilea Pharmaceutica Ltd, CHF 1.2 million, commercialization, Cresemba®, David Veitch, fungal infections, global sales, invasive fungal infections, Isavuconazole, Japan, market data, Market Growth, pharmaceutical industry, sales milestone
(IN BRIEF) SCHOTT Pharma’s AGM on February 4, 2025, revealed strong fiscal results for FY 2024, including exceeding revenue targets and a promotion to the MDAX. Shareholders approved all agenda items, including the appointment of Dr. Wolfram Carius to the … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Annual General Meeting, appointment, corporate growth, dividend payout, Dr. Wolfram Carius, GLP-1 drugs, green financing, homecare solutions, INNOVATION, KPMG, leadership, Management, MDAX, mRNA, pharma industry, profitability, revenue guidance, SCHOTT Pharma, shareholder approval, shareholder engagement, Supervisory Board
(IN BRIEF) On World Cancer Day, Servier reaffirms its commitment to the fight against cancer by focusing on oncology as a central part of its Research & Development efforts. The company emphasizes the importance of understanding the personal experiences of … Read the full press release
Posted in Business, Financial, France, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged brain tumors, cancer burden, Cancer Prevention, cancer research, cancer treatments, cancer-related deaths, digestive cancers, Early Detection, educational resources, global rankings, hematological cancers, immuno-oncology, oncology, patient experience, patient experiences, PatientView, personalized care, rare cancers, research development, screening, Servier, SHAPE program, targeted therapies, therapeutic solutions, U.S., UICC, Union for International Cancer Control, United by Unique, World Cancer Day, World Cancer Day campaign
(IN BRIEF) AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for approval as a monotherapy to treat limited-stage small cell lung cancer (LS-SCLC) in patients whose disease … Read the full press release
Posted in Business, European Union, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged ADRIATIC Phase III trial, AstraZeneca, CHMP, disease progression, durvalumab, EMA, European Medicines Agency, hazard ratio, Imfinzi, immunotherapy, limited-stage small cell lung cancer, LS-SCLC, monotherapy, overall survival, platinum-based chemoradiation therapy, progression-free survival, regulatory review, safety profile, Small cell lung cancer, Suresh Senan, survival outcomes, Susan Galbraith, The New England Journal of Medicine, treatment approval
(IN BRIEF) Marks & Spencer (M&S) and YoungMinds have launched a competition for young people across the UK to design a sweatshirt or hoodie for the 2025 Hello Yellow kidswear collection. This initiative, which coincides with World Mental Health Day, … Read the full press release
Posted in Apparel, Fashion & Beauty, Art & Culture, Business, Environment, Financial, Healthcare, Industrial, Investment, Management, News, Non Profit, Retail, Technology, United Kingdom
Tagged Children’s Mental Health Week, creativity, design competition, fundraising initiative, Hello Yellow, hoodie, kidswear collection, Laura Bunt, M&S, M&S x YoungMinds partnership, Marks & Spencer, mental health awareness, mental health resources, mental health support, partnership, Rochelle Humes, social impact, sustainability, sweatshirt, UK competition, Victoria McKenzie-Gould, World Mental Health Day, young designers, young people, YoungMinds, YoungMinds charity, £3 million fundraising, £5 million goal
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?